|
English
|
正體中文
|
简体中文
|
2814002
|
|
???header.visitor??? :
27267184
???header.onlineuser??? :
1247
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"uttenreuther fischer martina m"???jsp.browse.items-by-author.description???
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 國立臺灣大學 |
2012 |
LUX-breast 1: Randomized, phase III trial of afatinib and vinorelbine versus trastuzumab and vinorelbine in patients with HER2-overexpressing metastatic breast cancer (MBC) failing one prior trastuzumab treatment.
|
Harbeck, Nadia; Im, Seock-Ah; Huang, Chiun-Sheng; Im, Young-Hyuck; Xu, Binghe; Hurvitz, Sara A.; Lee, Keun-Seok; Ahn, Jin-Hee; Mehta, Ajay O.; Arora, Rajender Singh; Sun, Qiang; Qin, Shukui; Jacob, Linu Abraham; Jassem, Jacek; Staroslawka, Elzbieta; Sufliarsky, Jozef; Wojtukiewicz, Marek; Lahogue, Annick; Uttenreuther-Fischer, Martina Maria; Piccart-Gebhart, Martine J.; 黃俊升 |
| 國立臺灣大學 |
2012 |
LUX-breast 2: Phase II, open-label study of oral afatinib in HER2-overexpressing metastatic breast cancer (MBC) patients (pts) who progressed on prior trastuzumab (T) and/or lapatanib (L)
|
Hickish, Tamas; Tseng, Ling-Ming; Mehta, Ajay O.; Tsang, Janice; Kovalenko, Nadezhda; Udovitsa, Dmitry; Pelling, Katy; Uttenreuther-Fischer, Martina Maria; Huang, Chiun-Sheng; 黃俊升 |
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
